$Merck & Co (MRK.US)$ 🎉 FDA Approves CAPVAXIVE™ (Pneumococc...
⇨ for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults 🫁
» CAPVAXIVE (V116) protects against most strains causing illness in adults over 50. 🛡️
» Effective in people who've never had a pneumococcal vaccine or already have one as demonstrated in Ph3 trials.
» Effective in people who've never had a pneumococcal vaccine or already have one as demonstrated in Ph3 trials.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
182608752 : FDA always be great.